Cyclin D1 in breast cancer pathogenesis.
Taking a perspective on available evidence that emphasizes relevance to human disease, cyclin D1 is solidly established as an oncogene with an important pathogenetic role in breast cancer and other human tumors. However, the precise cellular mechanisms through which aberrant cyclin D1 expression drives human neoplasia are less well established. Indeed, emerging evidence suggests that cyclin D1 might act, predominantly or at least in part, through pathways that do not involve its widely accepted function as a cell cycle regulator. Although therapeutic exploitation of the role of cyclin D1 as a molecular driver of breast cancer carries great promise, it is also suggested that direct targeting of the cyclin D1 gene or gene products may prove more successful than approaches that rely on arguably incomplete knowledge of the oncogenic mechanisms of cyclin D1.
Arnold
Andrew
A
Center for Molecular Medicine, University of Connecticut School of Medicine, 263 Farmington Ave, Farmington, CT 06030-3101, USA. molecularmedicine@uchc.edu
Papanikolaou
Alexandros
A
D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism; D019938:Cyclin D1 / Q000235:genetics*; D005260:Female; D006801:Humans; D015513:Oncogene Proteins / Q000235:genetics*
D015513:Oncogene Proteins; D019938:Cyclin D1